Latest filing published 05 Jan 2024 for Cell MedX Corp.
No signal scores available.
Joao daCosta is a declared insider of Cell MedX Corp, with filings sourced from SEDI. We count 3 filings; the first trade dates from 8 June 2020 and the latest from 29 December 2023.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 January 2024, reports a transaction in Cell MedX Corp. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations